Leukemia Research
Volume 30, Issue 12 , Pages 1585-1586, December 2006

Antibodies contained in “M” component of some patients with multiple myeloma are directed to food antigens?

  • Zorica Juranić

      Affiliations

    • Institute for Oncology and Radiology of Serbia, Belgrade, Serbia and Montenegro
    • Corresponding Author InformationCorresponding author at: Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia and Montenegro. Tel.: +381 112067290.
  • ,
  • Jelena Radic

      Affiliations

    • Institute for Oncology and Radiology of Serbia, Belgrade, Serbia and Montenegro
  • ,
  • Aleksandra Konic-Ristic

      Affiliations

    • Institute for Oncology and Radiology of Serbia, Belgrade, Serbia and Montenegro
  • ,
  • Svetislav Jelic

      Affiliations

    • Institute for Oncology and Radiology of Serbia, Belgrade, Serbia and Montenegro
  • ,
  • Biljana Mihaljevic

      Affiliations

    • School of Medicine, University of Belgrade, Belgrade, Serbia and Montenegro
  • ,
  • Irina Besu

      Affiliations

    • Institute for Oncology and Radiology of Serbia, Belgrade, Serbia and Montenegro

Received 26 January 2006 published online 07 March 2011.

Abstract 

Multiple myeloma is malignant disease that is characterized in most patients, by the presence in the serum of monoclonal gamma globulins, which in agarose gel after electrophoresis appear as protein band of restricted mobility, “M” component.

The aim of this study was to determine are the antibodies contained in M-component directed to some antigen chronically present in the organism, to some of food antigens.

Seventeen patients with secretory plasmacytoma were included in the study: eight of them had IgG(kappa), three had IgG(lambda), and one had biclonal IgG(kappa) and IgA(kappa), while two had IgA(kappa), the other two IgA(lambda) and one IgM(lambda) as paraproteins. M-proteins were detected analyzing patients’ sera by agarose gel electrophoresis in 0.09M barbital buffer. The each M-protein was confirmed by immunotyping (immunofixation) with corresponding antihuman antibodies directed to heavy or light chains of immunoglobulins. After the patients serum separation on agarose gel by electrophoresis, fresh 0.4% solution of crude gliadin (Sigma) in 1% SDS was put over the slides for immunoprecipitation.

Preliminary results showed the interaction of gliadin with patient's serum proteins present in the protein fraction of the same mobility as it was the mobility of the M-component, in 6 from 17 investigated sera.

These results are the first reporting that in sera of some patients with multiple myeloma antibodies from M-component could be directed to some of gliadin antigens.

As the serum antigliadin immunoreactivity is present in patients with gluten intolerance, celiac disease, it could be of importance to elucidate is the multiple myeloma more severe form of gluten intolerance than celiac disease.

Keywords: Multiple myeloma, Food intolerance, Coeliac disease, Antigliadin immunoreactivity, M-component, Plasmacytoma, Calreticulin

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(06)00049-X

doi:10.1016/j.leukres.2006.01.013

Leukemia Research
Volume 30, Issue 12 , Pages 1585-1586, December 2006